Nucleic Acid Nanoparticles (NANPs): A New Dawn for Immunotherapy and Vaccines
Dr. Kirill Afonin's team found that building DNA aptamers into fibrous nucleic acid nanoparticles can tune down the immune response the particles trigger in cells.
Featured journal
ACS Applied Materials & Interfaces
Features based on peer-reviewed papers published in ACS Applied Materials & Interfaces.